• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Schlumberger M, Newbold K, Hasan B, Marreaud S, Assele S, Licitra LF, Schoffski P, Leboulleux S, Locati L, Godbert Y, Rohmer V, Jarzab B, Domenico S, Bechter OE, Zanetta S, Capdevila J, Kapiteijn E, Bastholt L. A randomized doubled blind phase II study exploring the safety and efficacy of nintedanib (BIBF1120) as second line therapy for patients (pts) with differentiated thyroid carcinoma (DTC) progressing after first line therapy: EORTC 1209. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.6021] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
2
Pietro C, Egidio S, Domenico S. Two fractions of cryoactivable prorenin in human plasma. Biochem Med 1979;22:264-5. [PMID: 518581 DOI: 10.1016/0006-2944(79)90012-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA